Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into manufacturing and selling Active Pharmaceutical Ingredients (API’s), Pharma Intermediates, Specialty Chemicals as well as Formulations.
Financial Results:
Aarti Drugs Ltd reported Revenues for Q1FY25 of ₹493.00 Crores down from ₹592.00 Crore year on year, a fall of 16.72%.
Total Expenses for Q1FY25 of ₹458.00 Crores down from ₹540.00 Crores year on year, a fall of 15.19%.
Consolidated Net Profit of ₹27.00 Crores down 32.5% from ₹40.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹2.93, down 31.38% from ₹4.27 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.